The Procter & Gamble Company (PG)

NYSE: PG · USD

—

Dự phòng tiếng AnhVI

Hiển thị bản gốc tiếng Anh trong khi đang dịch

Báo cáo này chưa được dịch. Hãy làm mới sau vài phút khi hàng đợi dịch xử lý xong.

StockMarketAgent Research · Analyzed 2026-09-09

Our latest published analysis: PG rated Reduce

The Procter & Gamble Company's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$126 / share

Potential value

$204 / share

Upside to FV

-13.1%

Moat

5.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$340.1B
P/E (forward)	21.1x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

P/E (forward): 21.1x
Market cap: $340.1B

Item	P1	P2	P3	P4	P5	Trend
Period	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30	Trend
Revenue	$80.19B	$82.01B	$84.04B	$84.28B	$87.03B	+2.1%
Gross profit	$38.03B	$39.25B	$43.19B	$43.12B	$43.67B	+3.5%
Operating income	$17.81B	$18.13B	$18.55B	$20.45B	$19.75B	+2.6%
Net income	$14.74B	$14.65B	$14.88B	$15.97B	$16.05B	+2.1%
EPS (diluted)	$5.81	$5.90	$6.02	$6.51	$6.62	+3.3%
EBITDA	$21.24B	$21.77B	$22.58B	$23.92B	$21.25B	+0.0%
R&D	$2.00B	$2.00B	$2.00B	$2.10B	$2.10B	+1.2%
SG&A	$20.22B	$21.11B	$23.31B	$22.67B	$23.92B	+4.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	—	—	—	—	—	—	Bán
ABT	Abbott Laboratories	—	—	—	—	—	—	Giảm
ACN	Accenture plc	—	—	—	—	—	—	Giữ
ADM	Archer-Daniels-Midland Company	—	—	—	—	—	—	Giảm
BF.B	Brown-Forman Corporation Class B	—	—	—	—	—	—	Mua
CAG	Conagra Brands, Inc.	—	—	—	—	—	—	Mua mạnh

Base and Bull scenarios

Base60%

Price target

$126.47

-13.1% from spot

The base case is modest compounding, not a sharp reacceleration. A miss against either annual revenue anchor would disconfirm it by FY2028.

Revenue meets the explicit FY2027 and FY2028 annual anchors.
Margins remain near FY2026 levels without assumed expansion.
Cash conversion remains strong enough to fund recurring investment.

Bull20%

Price target

$204.04

+40.2% from spot

Upside requires FY2028 earnings to meet the forecast, FY2026 cash generation to persist, and the FY2024-to-FY2026 decline in diluted shares to continue. A miss against the FY2028 forecast or weaker operating cash would disconfirm this path.

FY2028 earnings reach the upper part of the analyst forecast range.
Shipment and consumption gaps clear across major regions.
High-velocity products preserve retailer relevance and margins.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($126.47). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	2.0%	2.5%	3.0%	3.5%
5.0%	$151	$163	$180	$204	$244
6.0%	$131	$138	$146	$158	$173
7.0%	$117	$121	$126	$133	$141
8.0%	$107	$110	$113	$117	$122
9.0%	$99.4	$102	$104	$107	$110

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Forward P/E21.1

P25 n/aP50 n/aP75 n/a

Trailing P/E22.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

Deeper analysis on PG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this PG report

What is the latest published PG stock rating?

The Procter & Gamble Company is shown with Reduce in the latest published report, analyzed 2026-09-09. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PG analysis?

The full latest published report, analyzed 2026-09-09, lives at /stocks/PG/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for PG?

The latest published report analyzed 2026-09-09 gives PG a fair value of USD 126 and a potential value of USD 204. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the PG page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-09). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

ReducePG · Fair value $126-13.1%

Read full analysis →

Category	Score	Reading
Valuation	3.0
Management	6.5
Balance Sheet	4.0
Profitability	7.5
Revenue Growth	4.5
Risk Assessment	6.0
Competitive Moat	5.5
Earnings Quality	6.0
Capital Efficiency	7.5

The Procter & Gamble Company (PG)

Our latest published analysis: PG rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · PG

Valuation

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

Deeper analysis on PG

Frequently asked questions

Lịch sử xếp hạng